Pancreatic Cancer Research

ResearcherYamaguchi UniversityActive in the last 2 years

Koji Tamada

Matched on ORCID iD 0000-0002-3098-2565; OpenAlex author ID A5002617255. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Therapeutic Efficacy of IL7/CCL19-Expressing CAR-T Cells in Intractable Solid Tumor Models of Glioblastoma and Pancreatic Cancer. Last author DOI 10.1158/2767-9764.crc-24-0226↗
  2. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0226707↗
  3. A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population. Co-author DOI 10.3892/ijo.2014.2603↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masao Nakajima · 1 shared paper, 2024 · strength 0.23
  2. Hiroaki Nagano · 1 shared paper, 2024 · strength 0.23
  3. Keisuke Ohta · 1 shared paper, 2024 · strength 0.23
  4. Erica Yada · 1 shared paper, 2020 · strength 0.08
  5. Satoshi Wada · 1 shared paper, 2020 · strength 0.08
  6. Tetsuro Sasada · 1 shared paper, 2020 · strength 0.08
  7. Yutaro Kubota · 1 shared paper, 2020 · strength 0.08
  8. Takehiko Yokobori · 1 shared paper, 2020 · strength 0.08
  9. Ryotaro Ohkuma · 1 shared paper, 2020 · strength 0.08
  10. Tomoko Norose · 1 shared paper, 2020 · strength 0.08
  11. Masaaki Oka · 1 shared paper, 2014 · strength 0.03
  12. Yusaku Watanabe · 1 shared paper, 2014 · strength 0.03
  13. Yoshitaro Shindo · 1 shared paper, 2014 · strength 0.03
  14. Nobuaki Suzuki · 1 shared paper, 2014 · strength 0.03
  15. Ryouichi Tsunedomi · 1 shared paper, 2014 · strength 0.03
  16. Hideyuki Saya · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.